
About Amgen Technology Private Limited
Data last updated:
Amgen Technology Private Limited is a foreign private limited company based in Mumbai, Maharashtra, India, a subsidiary of Amgen Worldwide Holdings B V. It operates in the research and development sector. It was incorporated on 08 March 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U62099MH2007FTC168485. Its GSTIN is 27AAGCA2156C1Z3 (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Naveen Gullapalli (Whole-Time Director) and Mihir Kumar Ojha (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Park, Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹166.38 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹12.46 Cr (net margin 7.5%) and EBITDA of ₹29.68 Cr (EBITDA margin 17.8%). Revenue has grown at a compounded annual rate (CAGR) of 79% over three years and 42% over five years.
The company has about 3,234 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Amgen. The company has 1 deal on record (1 secondary share transfer); the latest was in November 2008. Its 5 peer companies in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development) are compared by revenue, 2 larger and 3 smaller; the largest is Laxai Life Sciences Private Limited with revenue of ₹178 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website amgen.com.
Company details
CIN history
Amgen Technology has one previous CIN (Corporate Identification Number): U24110MH2007FTC168485. The current CIN is U62099MH2007FTC168485, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U62099MH2007FTC168485 | Current |
| U24110MH2007FTC168485 | Previous |
Contact details
Amgen Technology Private Limited's registered office is in Mumbai, Maharashtra. Its website is amgen.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address10th Floor Nesco Tower 4 C Wing Western Express Highway Goregaon (E) Nesco I., T. Park, Mumbai, Maharashtra, India – 400063
- IndustryResearch & Development, Research & Development
To see the full contact details of Amgen Technology Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Amgen Technology is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Amgen Technology Private Limited, buy the company report.
Financials of Amgen Technology Private Limited
FY 2024 filings availableAmgen Technology Private Limited reported revenue of ₹166.38 Cr (up 601% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 42% over five years, including 601% growth in the latest year. EBITDA rose 450% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹29.68 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.46 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.8% | ||||
| Net Profit Margin | 7.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Amgen Technology Private Limited, buy the company report.
Board of directors of Amgen Technology Private Limited
Amgen Technology has 5 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mansi Jayantilal Malkan | Director | 15 Sep 2017 | 9 Years 2 Months | Current |
| David Ewan Foulstone | Director | 20 Mar 2024 | 2 Years 7 Months | Current |
| Ng Lian Eric Teck | Director | 31 Aug 2017 | 9 Years 2 Months | Current |
| Naveen Gullapalli Also directs: GG Consulting LLP, La Vista Farm LLP, Amgen Global Technology India Private Limited and 1 more | Whole-Time Director | 23 Apr 2025 | 1 Years 6 Months | Current |
| Mihir Kumar Ojha | Whole-Time Director | 09 May 2025 | 1 Years 6 Months | Current |
Peer comparison
Amgen Technology Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Laxai Life Sciences Private Limited | ₹178 Cr (FY 2024) | 37.0% | Hyderabad, Telangana, India | |||
| Aurigene Oncology Limited | ₹171.93 Cr (FY 2025) | -57.0% | Bangalore, Karnataka, India | |||
| Amgen Technology Private Limitedthis company | ₹166.38 Cr (FY 2025) | ₹12.46 Cr | 7.5% | 601.0% | 3,234 | Mumbai, Maharashtra, India |
| Jamp India Pharmaceuticals Private Limited | ₹155.09 Cr (FY 2025) | 19.0% | Ahmedabad, Gujarat, India | |||
| Raptim Research Private Limited | ₹146.15 Cr (FY 2025) | -4.0% | Navi Mumbai, Maharashtra, India | |||
| Synzeal Research Private Limited | ₹144.48 Cr (FY 2025) | 19.0% | Bavla, Gujarat, India |
To see the full peer comparison of Amgen Technology Private Limited, buy the company report.
Auditor
Amgen Technology Private Limited is audited by S R B C & CO LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S R B C & CO LLP | FY 2022 | 324982E |
Shareholding
The shareholding of Amgen Technology Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Amgen Technology Private Limited, buy the company report.
Deals & funding
Amgen Technology Private Limited has 1 deal on record (1 secondary share transfer); the latest was in November 2008.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2008 | Secondary share transfer | Undisclosed | Buyer: Amgen Worldwide Holdings B V Seller: Amgen International Inc |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Amgen Technology Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Amgen Technology Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Amgen Technology Private Limited has a workforce of 3,234 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 3,234 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Amgen Technology Private Limited, buy the company report.
GST
Amgen Technology has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCA2156C1Z3 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Amgen Technology Private Limited, buy the company report.
Recent activity
Amgen Technology Private Limited has 17 board changes on record since 2008: 5 appointments and 12 cessations. The latest: Mihir Kumar Ojha was appointed as Whole-Time Director on 09 May 2025.
8 earlier events are in the company report.
News
Frequently asked questions
Amgen Technology is an active foreign private limited company based in Mumbai, Maharashtra, India. The company works in the research and development industry. It was incorporated on 08 March 2007 (19+ years old) and is registered under CIN U62099MH2007FTC168485.
Amgen Technology has 5 current directors:
- Naveen Gullapalli - Whole-Time Director
- Mihir Kumar Ojha - Whole-Time Director
- Mansi Jayantilal Malkan - Director
- David Ewan Foulstone - Director
- Ng Lian Eric Teck - Director
The latest financial statements of Amgen Technology on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Amgen Technology is 27AAGCA2156C1Z3, registered in Maharashtra.
The CIN (Corporate Identification Number) of Amgen Technology is U62099MH2007FTC168485. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amgen Technology was incorporated on 08 March 2007, making it 19+ years old. It is registered with the Registrar of Companies, Mumbai.
Amgen Technology has 1 deal on record (1 secondary share transfer); the latest was in November 2008.
The peers of Amgen Technology by revenue are Laxai Life Sciences Private Limited, Aurigene Oncology Limited, Jamp India Pharmaceuticals Private Limited, Raptim Research Private Limited, Synzeal Research Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).
Mihir Kumar Ojha was appointed as Whole-Time Director on 09 May 2025. Naveen Gullapalli was appointed as Whole-Time Director on 23 Apr 2025. David Ewan Foulstone ceased to be Additional Director on 25 Sep 2024. Amgen Technology has 17 board changes on record in total.
Amgen Technology can be reached through the website amgen.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Amgen Technology is at 10th Floor Nesco Tower 4 C Wing Western Express Highway Goregaon E Nesco I., T. Park, Mumbai, Maharashtra, India – 400063.

